Article

New CEO for Israel's BioLineRx

August 12, 2016

Tel Aviv, Israel-based BioLineRx Ltd. announced that Philip A. Serlin has been named Chief Executive Officer, effective October 10, 2016.   Mr. Serlin joined the company in 2009 as Chief Financial and Operating Officer. He succeeds Kinneret Savitsky, Ph.D., who has served as CEO since 2010.  Dr. Savitsky will serve as scientific advisor to the Company through the end of March 2017.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Gen Li
Gen Li
Related Content
Joseph Paxton
August 14th 2025

Bridging the Gap Between AI-Powered Medical Imaging and Clinical Decision-Making in Precision Oncology: Are we there yet?

Josesph Paxton
Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement
August 14th 2025

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
Magellan AI Identifies and Optimizes Molecules Beyond the Public Domain
August 14th 2025

Magellan AI Identifies and Optimizes Molecules Beyond the Public Domain

Don Tracy, Associate Editor
Sujay Jadhav
August 14th 2025

Fail Fast, Save Smart: A Silicon Valley Approach to Drug Development Could Cut Costs and Improve Access

Sujay Jadhav
Peter Tummino
August 14th 2025

Computational Chemistry in Drug Discovery: Q&A with Dr. Peter Tummino

Mike Hollan
Credit: Shuo | stock.adobe.com
August 14th 2025

Six Essential Priorities for Life Sciences Chief Information Officers

Alister Campbell